Molecular Partners AG (MOLN) income statement
MOLNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$2.67−0.19 (-6.82%)
Close on Nov 18, 2026Market cap $107.60MP/E –Yield –
Molecular Partners AG financial ratios
See a number that looks wrong?